According to the standards of the international society of pediatric oncology (SIOP) and children's oncology group (COG), NGGCTs can be defined clinically by the elevation of AFP level (AFP >10 mg/L) in serum or CSF, which includes yolk sac tumors, immature teratoma, and embryonic carcinoma (24). The gene discussed is AFP; the disease is embryonal carcinoma.